SecBot SecBot
SC 13G ·Filed Oct 8, 2026

CLGN

CollPlant Biotechnologies Ltd
NEUTRAL
Impact 3/10
Horizonweeks Processed18d 22h ago SEC0001213900-26-107785
Passive investor 5%+ stake
Actionable Insight • Neutral

This is a routine passive disclosure by an insider; no activist intent is signaled. Monitor for any subsequent conversion to a 13D or changes in Sagy's holdings in future filings.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d
CLGN ▼ -7.30% at T+5d
NEUTRAL call -7.30% · α vs SPY -7.03% · entry $3.97 → $3.68
Next anchor: T+20d in 9d
Latest observation: T+11 -1.07% FF3 residual α
Entry = T+0 close
Oct 8, 2026
via day close
T+1d
-11.59%
call -11.59% · α -12.19%
$3.51
settled 18d ago
T+5d
-7.30%
call -7.30% · α -7.03%
$3.68
settled 12d ago
T+20d
Pending
in 9d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Insider Ami Sagy filed a Schedule 13G disclosing beneficial ownership of 163,709 ordinary shares (5.7% of shares outstanding) in CollPlant Biotechnologies Ltd. The filing is passive, with no intent to influence control, and the stake was acquired and is held for investment purposes only.

Key Financial Metrics

Stake
5.7%
Investor
Ami Sagy

Key Facts

  • Ami Sagy reported beneficial ownership of 163,709 ordinary shares, representing 5.7% of CollPlant Biotechnologies Ltd.
  • The stake is based on 2,866,715 ordinary shares outstanding as of September 30, 2026, reflecting a 1-for-10 reverse share split effective September 4, 2026.
  • The filing is made under Rule 13d-1(c), indicating a passive investment with no control intent.
  • Sagy certifies the securities were not acquired to change or influence control of the issuer.

Financial Impact

Insider holds 5.7% stake valued at approximately $163,709 (based on share count and no stated per-share price).

ownership percentage

Risk Factors

  • No material risk identified from this passive filing.
  • The small absolute stake size limits signaling value.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001213900-26-107785
Document: 0001213900-26-107785-index.html0001213900-26-107785
Document: 0001213900-26-107785.txt0001213900-26-107785
20 reports for CLGN
Performance horizon
100% Hit rate @ T+1 9 of 9 directional calls Went positive at some point 9 of 9 best @ T+60▲ +25.17%May 29, 2026
Filters
Rows
Reports for CLGN — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
3
NEUTRAL ★ 2/10
$3.88 $3.76▼ −3.22%▼ −3.75%$3.75 (−3.35%)
Oct 15, 2026
12d ago
6-K
BEARISH ★ 6/10
$3.68 $3.63▲ +1.49%▲ +0.39%$3.75 (−1.90%)
Oct 9, 2026
17d ago
6-K
BEARISH ★ 5/10
$4.02 $3.91▲ +2.74%▲ +2.72%$3.75 (+6.72%)
Oct 8, 2026
18d ago
SC 13G
NEUTRAL ★ 3/10
$3.97 $3.51▼ −11.59%▼ −12.19%$3.75 (−5.54%)
Oct 8, 2026
18d ago
SC 13D/A
NEUTRAL ★ 3/10
$3.97 $3.51▼ −11.59%▼ −12.19%$3.75 (−5.54%)
Oct 6, 2026
21d ago
6-K
NEUTRAL ★ 3/10
$3.39 $3.46▲ +2.06%▲ +2.30%$3.75 (+10.62%)
Sep 30, 2026
26d ago
6-K
BEARISH ★ 7/10
$3.57 $3.46▲ +3.08%▲ +3.82%$3.75 (−5.04%)
Sep 30, 2026
26d ago
Press Release
BEARISH ★ 5/10
$3.57 $3.46▲ +3.08%▲ +3.82%$3.75 (−5.04%)
Sep 24, 2026
4w ago
6-K
NEUTRAL ★ 4/10
$4.12 $4.25▲ +3.16%▲ +2.61%$3.75 (−8.98%)
Sep 22, 2026
4w ago
6-K
NEUTRAL ★ 3/10
$3.85 $4.04▲ +4.94%▲ +5.66%$3.75 (−2.60%)
Showing 10 of 20

US Market Status

Market Closed — Opens in 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 8, 2026